DE1695523A1 - Substituierte Benzimidazole und Verfahren zu ihrer Herstellung - Google Patents

Substituierte Benzimidazole und Verfahren zu ihrer Herstellung

Info

Publication number
DE1695523A1
DE1695523A1 DE19671695523 DE1695523A DE1695523A1 DE 1695523 A1 DE1695523 A1 DE 1695523A1 DE 19671695523 DE19671695523 DE 19671695523 DE 1695523 A DE1695523 A DE 1695523A DE 1695523 A1 DE1695523 A1 DE 1695523A1
Authority
DE
Germany
Prior art keywords
lower alkyl
amino
acid
methyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19671695523
Other languages
German (de)
English (en)
Inventor
Matzuk Alexander Richard
Harvey Schwam
Tsung-Ying Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1695523A1 publication Critical patent/DE1695523A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19671695523 1966-12-02 1967-12-01 Substituierte Benzimidazole und Verfahren zu ihrer Herstellung Pending DE1695523A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59860766A 1966-12-02 1966-12-02
US76888468A 1968-10-18 1968-10-18

Publications (1)

Publication Number Publication Date
DE1695523A1 true DE1695523A1 (de) 1971-04-15

Family

ID=27083113

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19671695523 Pending DE1695523A1 (de) 1966-12-02 1967-12-01 Substituierte Benzimidazole und Verfahren zu ihrer Herstellung

Country Status (6)

Country Link
US (1) US3586694A (enExample)
CH (1) CH512494A (enExample)
DE (1) DE1695523A1 (enExample)
FR (1) FR1580823A (enExample)
GB (1) GB1200907A (enExample)
NL (1) NL6715600A (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901901A (en) * 1973-06-19 1975-08-26 Syntex Inc 5(6)-benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
DE2340571C3 (de) * 1973-08-10 1982-01-21 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von heterocyclischen Verbindungen
US4109093A (en) * 1975-01-14 1978-08-22 Produits Chimiques Ugine Kuhlmann Process for making 2-(4'-aminophenyl) 5-amino benzimidazole
GB1574822A (en) * 1976-03-23 1980-09-10 Lafon Labor Acetohydroxamic acid derivatives and pharmaceutical compositions thereof
FR2658511B1 (fr) * 1990-02-16 1992-06-19 Union Pharma Scient Appl Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant.
DE4007535A1 (de) * 1990-03-09 1991-09-12 Hoechst Ag Wasserunloesliche azofarbmittel, ihre herstellung und verwendung
PT98674B (pt) * 1990-08-15 1999-01-29 British Bio Technology Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de imidazole e de seus intermedriarios
PT98673B (pt) * 1990-08-15 1999-01-29 British Bio Technology Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios
GB9122988D0 (en) * 1991-10-30 1991-12-18 Ici Plc Heterocyclic compounds
GB9127279D0 (en) * 1991-12-23 1992-02-19 Ici Plc Heterocyclic derivatives
US5612352A (en) * 1992-04-10 1997-03-18 Zeneca Limited Heterocyclic compounds
GB9211796D0 (en) * 1992-06-04 1992-07-15 Ici Plc Heterocyclic derivatives
GB9216721D0 (en) * 1992-08-06 1992-09-23 Ici Plc Therapeutic heterocyclic derivatives
GB9218334D0 (en) * 1992-08-28 1992-10-14 Ici Plc Heterocyclic compounds
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US6130333A (en) * 1998-11-27 2000-10-10 Monsanto Company Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
JP2007521296A (ja) * 2003-07-01 2007-08-02 メルク　エンド　カムパニー　インコーポレーテッド 高眼圧の治療のための眼科用組成物
CN1988903A (zh) * 2004-07-20 2007-06-27 默克公司 用于治疗高眼压症的眼用组合物
CN101124207A (zh) * 2004-09-21 2008-02-13 阿特西斯公司 显示出crth2受体拮抗作用的苯并咪唑乙酸类和其用途
US8501957B2 (en) * 2008-12-10 2013-08-06 China Medical University Benzimidazole compounds and their use as anticancer agents

Also Published As

Publication number Publication date
US3586694A (en) 1971-06-22
GB1200907A (en) 1970-08-05
CH512494A (de) 1971-09-15
NL6715600A (enExample) 1968-06-04
FR1580823A (enExample) 1969-09-12

Similar Documents

Publication Publication Date Title
DE1695523A1 (de) Substituierte Benzimidazole und Verfahren zu ihrer Herstellung
DE2144080A1 (de) Heterocyclische Verbindungen, Verfahren zu ihrer Herstellung und ihrer Verwendung
DE1770460A1 (de) Verfahren zur Herstellung von neuen Indolderivaten
DE1670684A1 (de) Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
DE2135678A1 (de) beta agonistisch wirksame Aminver bindungen
DE3132882A1 (de) Neue piperazinone, ihre herstellung und verwendung
DE2322880C2 (de) 4-(Imidazolin-2-ylamino)-2,1,3-benzothiadiazole und Verfahren zu deren Herstellung
DE69530988T2 (de) Benzimidazolderivate mit dopaminerger wirkung
DE1445904A1 (de) Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
DE2609289A1 (de) Verfahren zur herstellung von neuen indolylalkylpiperidinen
DE1595920A1 (de) 4-(omega-Piperazinoalkyl)-pyrazole,ihre Salze und Verfahren zu ihrer Herstellung
DE1493426A1 (de) In 4-Stellung substituierte 4'-tert.-Aminoalkoxy-biphenyle
DE1695435A1 (de) Indolyl-aliphatische Saeuren
DE2527677A1 (de) Verfahren zur herstellung von 2,4- dioxo-1,2,3,4-tetrahydro-s-triazino- eckige klammer auf 1,2-a eckige klammer zu -benzimidazolen
DE2737630A1 (de) Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2653147C2 (enExample)
CH641162A5 (de) Verfahren zur herstellung neuer phenylazacycloalkane.
DE3642497A1 (de) Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
CH498854A (de) Verfahren zur Herstellung von neuen Furazanderivaten
DE1545810A1 (de) Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
DE2417464A1 (de) Neue amine und verfahren zu ihrer herstellung
DE1768366C3 (de) 3-Hydroxy-alpha-(l-aminoäthyl)benzylalkohol-derivate und diese enthaltende Arzneimittel
DE1768606A1 (de) Verfahren zur Herstellung von Benzylalkoholderivaten
DE2024350C3 (de) 1-(Benzamidoäthyl)-4-(2-pyridyl)piperazine
AT256095B (de) Verfahren zur Herstellung von neuen substituierten α-(3-Indolyl)-säureamiden